Skip to navigation Skip to main content Skip to footer

Approved Research

The role and mechanism of matricellular protein CCN1 in the regulation of diabetic sarcopenia

Principal Investigator: Dr Ping Zhu
Approved Research ID: 154387
Approval date: February 27th 2024

Lay summary

What is this Research About?

This project delves into understanding the relationship between a specific protein called CCN1 and muscle loss in people with diabetes, a condition termed "diabetic sarcopenia."

Why is it Important?

Muscle health is crucial for our daily activities, from walking to lifting objects.  In diabetes, there's a noticeable decline in muscle strength and mass, which affects quality of life.  The protein CCN1 might play a pivotal role in this muscle deterioration, but we aren't sure how.

The Aims of the Project:

Explore how CCN1 is involved in muscle health and deterioration in diabetes.

Understand the detailed processes and pathways in which CCN1 operates in the muscle tissues of diabetic individuals.

Determine if changes in CCN1 can alter the course of muscle loss in diabetes.

Why are we Doing this Research?

Muscle and Diabetes Link: There's a clear link between diabetes and muscle loss, but the deeper reasons for this are still blurry.  CCN1 might be one of the culprits.

CCN1's Many Roles: CCN1 is like a multitasking protein.  It's involved in inflammation, tissue repair, and more.  We want to see how it affects muscles specifically in the context of diabetes.

Potential Solutions: If we understand the role of CCN1 in diabetic muscle loss, we might find ways to prevent or reduce this muscle deterioration.

How Long Will it Take?

The project is planned to last for 3 years.  In this time, we'll use lab experiments, study muscle tissues, and use advanced techniques to get insights about CCN1 and its effects.

What's the Benefit for Everyone?

Understanding the role of CCN1 in diabetic muscle loss has several broad advantages:

Better Patient Care: If doctors know about the connection between CCN1 and muscle loss, they can diagnose and treat patients better.

Possible New Treatments: In the future, this research might lead to new drugs or therapies targeting CCN1, offering a new way to combat muscle loss in diabetes.

Public Health: Muscle health is vital for independence, especially in the elderly.  Preventing muscle loss can mean fewer hospital visits, reduced healthcare costs, and overall, a better quality of life for diabetic patients.

In simple words, this research is about finding out if a protein called CCN1 is a 'troublemaker' in causing muscle loss in diabetes.  If it is, we'll be one step closer to keeping muscles stronger in people with diabetes.